Characterization immuno-modulatory effects of Tecfidera: feasibility study. : Characterization of the immuno-modulatory effects of Tecfidera in multiple sclerosis patients: exploration of drug mechanism and methodological feasibility.

Medienart:

Klinische Studie

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

WHO International Clinical Trials Registry Platform - (2023) vom: 03. Apr. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: Tecfidera induced lymphocytopenia
Recruitment Status: Recruiting
Study Type: Observational non invasive

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 2016-09-27, Last updated: 2023-04-06

ICTRP ID:

NTR6096
NL5908
: CHDR1519

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO004470559